These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 32879346)

  • 1. Dopamine D1 receptor signalling in dyskinetic Parkinsonian rats revealed by fiber photometry using FRET-based biosensors.
    Jones-Tabah J; Mohammad H; Hadj-Youssef S; Kim LEH; Martin RD; Benaliouad F; Tanny JC; Clarke PBS; Hébert TE
    Sci Rep; 2020 Sep; 10(1):14426. PubMed ID: 32879346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-Content Single-Cell Förster Resonance Energy Transfer Imaging of Cultured Striatal Neurons Reveals Novel Cross-Talk in the Regulation of Nuclear Signaling by Protein Kinase A and Extracellular Signal-Regulated Kinase 1/2.
    Jones-Tabah J; Martin RD; Tanny JC; Clarke PBS; Hébert TE
    Mol Pharmacol; 2021 Dec; 100(6):526-539. PubMed ID: 34503973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Behavioral and cellular dopamine D
    Lanza K; Meadows SM; Chambers NE; Nuss E; Deak MM; Ferré S; Bishop C
    Neuropharmacology; 2018 Aug; 138():304-314. PubMed ID: 29936243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential enhancement of ERK, PKA and Ca
    Mariani LL; Longueville S; Girault JA; Hervé D; Gervasi N
    Neurobiol Dis; 2019 Oct; 130():104506. PubMed ID: 31220556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Persistent activation of the D1R/Shp-2/Erk1/2 pathway in l-DOPA-induced dyskinesia in the 6-hydroxy-dopamine rat model of Parkinson's disease.
    Fiorentini C; Savoia P; Savoldi D; Barbon A; Missale C
    Neurobiol Dis; 2013 Jun; 54():339-48. PubMed ID: 23328768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 5alpha-reductase inhibitors dampen L-DOPA-induced dyskinesia via normalization of dopamine D1-receptor signaling pathway and D1-D3 receptor interaction.
    Fanni S; Scheggi S; Rossi F; Tronci E; Traccis F; Stancampiano R; De Montis MG; Devoto P; Gambarana C; Bortolato M; Frau R; Carta M
    Neurobiol Dis; 2019 Jan; 121():120-130. PubMed ID: 30261284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Buspirone anti-dyskinetic effect is correlated with temporal normalization of dysregulated striatal DRD1 signalling in L-DOPA-treated rats.
    Azkona G; Sagarduy A; Aristieta A; Vazquez N; Zubillaga V; Ruíz-Ortega JA; Pérez-Navarro E; Ugedo L; Sánchez-Pernaute R
    Neuropharmacology; 2014 Apr; 79():726-37. PubMed ID: 24333147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of dopamine D1 receptor-mediated ERK1/2 activation in the parkinsonian striatum and their modulation by metabotropic glutamate receptor type 5.
    Fieblinger T; Sebastianutto I; Alcacer C; Bimpisidis Z; Maslava N; Sandberg S; Engblom D; Cenci MA
    J Neurosci; 2014 Mar; 34(13):4728-40. PubMed ID: 24672017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reciprocal cross-sensitization of D1 and D3 receptors following pharmacological stimulation in the hemiparkinsonian rat.
    Lanza K; Chemakin K; Lefkowitz S; Saito C; Chambers N; Bishop C
    Psychopharmacology (Berl); 2020 Jan; 237(1):155-165. PubMed ID: 31435690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. D1 dopamine receptor supersensitivity in the dopamine-depleted striatum results from a switch in the regulation of ERK1/2/MAP kinase.
    Gerfen CR; Miyachi S; Paletzki R; Brown P
    J Neurosci; 2002 Jun; 22(12):5042-54. PubMed ID: 12077200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopamine D3 Receptor Modulates l-DOPA-Induced Dyskinesia by Targeting D1 Receptor-Mediated Striatal Signaling.
    Solís O; Garcia-Montes JR; González-Granillo A; Xu M; Moratalla R
    Cereb Cortex; 2017 Jan; 27(1):435-446. PubMed ID: 26483399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of 5-HT1A receptor stimulation on striatal and cortical M1 pERK induction by L-DOPA and a D1 receptor agonist in a rat model of Parkinson's disease.
    Lindenbach D; Dupre KB; Eskow Jaunarajs KL; Ostock CY; Goldenberg AA; Bishop C
    Brain Res; 2013 Nov; 1537():327-39. PubMed ID: 24060645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Levodopa/Benserazide Loaded Microspheres Alleviate L-dopa Induced Dyskinesia through Preventing the Over-Expression of D1R/Shp-2/ERK1/2 Signaling Pathway in a Rat Model of Parkinson's Disease.
    Wan Y; Wu N; Song L; Wang X; Liu Z; Yuan W; Gan J
    Front Aging Neurosci; 2017; 9():331. PubMed ID: 29093677
    [No Abstract]   [Full Text] [Related]  

  • 14. Loss of synaptic D1 dopamine/N-methyl-D-aspartate glutamate receptor complexes in L-DOPA-induced dyskinesia in the rat.
    Fiorentini C; Rizzetti MC; Busi C; Bontempi S; Collo G; Spano P; Missale C
    Mol Pharmacol; 2006 Mar; 69(3):805-12. PubMed ID: 16365282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Striatal inhibition of PKA prevents levodopa-induced behavioural and molecular changes in the hemiparkinsonian rat.
    Lebel M; Chagniel L; Bureau G; Cyr M
    Neurobiol Dis; 2010 Apr; 38(1):59-67. PubMed ID: 20060905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A role for BET proteins in regulating basal, dopamine-induced and cAMP/PKA-dependent transcription in rat striatal neurons.
    Jones-Tabah J; Martin RD; Chen JJ; Tanny JC; Clarke PBS; Hébert TE
    Cell Signal; 2022 Mar; 91():110226. PubMed ID: 34974082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. D1 dopamine receptor stimulation impairs striatal proteasome activity in Parkinsonism through 26S proteasome disassembly.
    Barroso-Chinea P; Thiolat ML; Bido S; Martinez A; Doudnikoff E; Baufreton J; Bourdenx M; Bloch B; Bezard E; Martin-Negrier ML
    Neurobiol Dis; 2015 Jun; 78():77-87. PubMed ID: 25766677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. L-DOPA treatment selectively restores spine density in dopamine receptor D2-expressing projection neurons in dyskinetic mice.
    Suárez LM; Solís O; Caramés JM; Taravini IR; Solís JM; Murer MG; Moratalla R
    Biol Psychiatry; 2014 May; 75(9):711-22. PubMed ID: 23769604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dopamine receptor cooperativity synergistically drives dyskinesia, motor behavior, and striatal GABA neurotransmission in hemiparkinsonian rats.
    Kiessling CY; Lanza K; Feinberg E; Bishop C
    Neuropharmacology; 2020 Sep; 174():108138. PubMed ID: 32492451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Levodopa/benserazide microsphere (LBM) prevents L-dopa induced dyskinesia by inactivation of the DR1/PKA/P-tau pathway in 6-OHDA-lesioned Parkinson's rats.
    Xie CL; Wang WW; Zhang SF; Yuan ML; Che JY; Gan J; Song L; Yuan WE; Liu ZG
    Sci Rep; 2014 Dec; 4():7506. PubMed ID: 25511986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.